Skip to main content

Technological offer

Available technologies catalogue

Available Technological Offer

Technological category
A new strain of the Blautia genus has been detected, isolated and identified, and the laboratory tests have found postbiotic properties related with the protection of cells against oxidation and the good functioning of metabolism.
New family of compounds with demonstrated in vitro efficacy against intracellular parasites responsible for leishmaniasis and American trypanosomiasis or Chagas disease. Pharmacokinetic and toxicity studies have been conducted in rats, as well as preliminary efficacy studies in a murine model.
Recombinant chimeric antigen used for the prevention or treatment of infections caused by Anaplasma phagocytophilum.
Live attenuated vaccine incorporating a variant of the Rift Valley Fever virus obtained in the laboratory by serial passages in the presence of a mutagenic agent, that could be the basis of a new vaccine strain with safety parameters not previously described.

Social Media